Rebalix
UBS · sheet of 10 September 2026
UBS · sheet of 10 September 2026ETF sheet · official issuer and register data
UBS Core SPI® ETF CHF dis
CH0131872431 · CH0131872431 · CHF · domicile Switzerland
equitySFDR art. 6
Index tracked: SPI® (TR)
- TER
- 0.09%+ trans. 0.01%
- Fund size
- —
- Tracking difference
- −1.13%3-year avg
- 🇮🇹 tax rate
- —white list not published
- Replication
- Physical (mixed: optimised/sampled)
- Income
- Distributingmonthly
Launch 18 Jul 2011 · costs from the KID as of 26 Aug 2026 · 3 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 2 Sept 2026
The investment objective of the sub-fund is to replicate the price and income performance before costs of the SPI® (Total Return). This sub-fund invests in equities of companies that are included in the SPI® and in equities that are not included in the SPI® but for which it has been announced that they will be included in the SPI® and other investments permitted under the fund contract. Sustainability risks are not systematically integrated as they are not taken into account as part of the index selection process. The fund's return depends primarily on…
Performance since series start (in euro) — base 100
18 Jul 2011 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +13.4% |
| 3 years | +34.0% |
| 5 years | +34.2% |
| 10 years | +128.1% |
| Since series start | +287.9% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 11.40% | 12.37% | 13.31% |
| Max drawdown | −11.41% | −16.55% | −24.00% |
| Sharpe | 0.96 | 0.43 | -0.03 |
| Sortino | 1.38 | 0.57 | -0.04 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · CH0131872431 · CH01318724311
RebalixCH0131872431 · CH0131872431 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +16.61% | +17.76% | −1.15% |
| 2024 | +5.12% | +6.18% | −1.06% |
| 2023 | +4.91% | +6.09% | −1.18% |
| 2022 | −17.29% | −16.48% | −0.81% |
| 2021 | +22.29% | +23.38% | −1.09% |
Distributions · per share, in CHF
Frequency: monthly · last 12 months: 0.6955 CHF (0.78% of NAV) · last ex-date 20 Apr 2026
| Year | Payments | Total (CHF) | Dividend yield |
|---|---|---|---|
| 2026 | 2 | 0.6955 | — |
| 2025 | 3 | 1.5265 | +2.07% |
| 2024 | 1 | 1.4835 | +2.07% |
| 2023 | 1 | 1.4175 | +2.04% |
| 2022 | 1 | 1.34 | +1.56% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Listing venues
ESMA register (FIRDS) and official exchange lists
UFUK · Börse Hamburg, Börse Hannover, Tradegate Exchange
+ 4 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/CH0131872431
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/CH0131872431
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · CH0131872431 · CH01318724312